Gainers
- BIMI International (NASDAQ:BIMI) stock increased by 17.6% to $1.4 during Wednesday's after-market session. This security traded at a volume of 173.1K shares come close, making up 23.1% of its average volume over the last 100 days. The company's market cap stands at $11.9 million.
- BioSig Technologies (NASDAQ:BSGM) shares increased by 10.09% to $1.2. The market value of their outstanding shares is at $42.3 million.
- Satsuma Pharmaceuticals (NASDAQ:STSA) stock increased by 10.05% to $4.16. The market value of their outstanding shares is at $131.1 million. As per the news, the Q4 earnings report came out yesterday.
- INmune Bio (NASDAQ:INMB) shares increased by 9.89% to $8.0. The company's market cap stands at $142.9 million.
- Stealth BioTherapeutics (NASDAQ:MITO) stock rose 9.39% to $0.63. The company's market cap stands at $36.2 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 9.1% to $0.39. The market value of their outstanding shares is at $17.6 million. As per the press release, Q4 earnings came out 4 days ago.
Losers
- Impel NeuroPharma (NASDAQ:IMPL) shares declined by 13.4% to $5.74 during Wednesday's after-market session. The market value of their outstanding shares is at $132.2 million.
- Sunshine Biopharma (NASDAQ:SBFM) shares fell 7.63% to $3.03. The company's market cap stands at $13.5 million.
- Myovant Sciences (NYSE:MYOV) shares declined by 5.78% to $11.91. The company's market cap stands at $1.1 billion.
- Codex DNA (NASDAQ:DNAY) shares fell 5.75% to $9.35. The company's market cap stands at $274.0 million.
- Alaunos Therapeutics (NASDAQ:TCRT) stock decreased by 5.65% to $0.69. At the close, Alaunos Therapeutics's trading volume reached 73.6K shares. This is 3.6% of its average volume over the last 100 days. The company's market cap stands at $148.0 million.
- Homology Medicines (NASDAQ:FIXX) shares fell 5.1% to $2.98. The company's market cap stands at $170.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
